Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

69 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Retrospective Cohort Study of Rebif® Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY)

NCT01207648

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +7 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site San Francisco, California, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Buffalo, New York, United States
View all 18 locations
View Trial Details
Completed

An Observational Study on the Progression of Clinically Isolated Syndrome to Multiple Sclerosis Over a 2-year Period

NCT01112657

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Kaohsiung Medical University, Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • Chang-Gung Memorial Hospital - Kaohsiung Branch Kaohsiung City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
  • National Taiwan University Hospital Taipei, Taiwan
View Trial Details
Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis

NCT00654927

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • USC, Keck School of Medicine Health Care Consultation Center Los Angeles, California, United States
  • Shepherd Center Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
View all 22 locations
View Trial Details
Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial

NCT00649792

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • HOPE Research Institute Phoenix, Arizona, United States
  • Neurological Associates Fayetteville, Arkansas, United States
  • Alta Bates Summit Medical Center - Research and Education Institute Berkeley, California, United States
View all 42 locations
View Trial Details
Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial

NCT00648908

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • USC, Keck School of Medicine Health Care Consultation Center Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Shepherd Center Atlanta, Georgia, United States
View all 32 locations
View Trial Details
Active, Not Recruiting

Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT

NCT05739643

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +20 more
Locations
  • Children's Hospital of Orange County (CHOC) Orange, California, United States
  • University of Michigan Hospitals - Michigan Medicine Ann Arbor, Michigan, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details

Related conditions